Filing Flows › Silence Therapeutics (SLN) › Q4 2025 › vs Q3 2025
Silence Therapeutics (SLN) Q4 2025 vs Q3 2025 (quarter over quarter)
Silence Therapeutics's revenue fell $125K (-79%) from $159K in Q3 2025 to $34K in Q4 2025.
Silence Therapeutics, Q4 2025: revenue $34K (-100% year over year), net loss $11.8M, operating cash flow −$17.3M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q4 2025 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $34K | $159K | −$125K | -79% |
| Other income, net | $691K | $5.3M | −$4.6M | -87% |
| Net loss | $11.8M | $21.0M | −$9.2M | -44% |
| Costs & expenses | $12.5M | $26.4M | −$13.9M | -53% |
| Operating costs | $12.5M | $26.4M | −$13.9M | -53% |
| Cost of revenue | $12K | $64K | −$52K | -81% |
| Research & development | $8.7M | $20.5M | −$11.8M | -57% |
| General & admin | $3.7M | $5.8M | −$2.1M | -36% |
| Operating cash sources | $17.4M | $11.0M | $6.4M | +58% |
| Depreciation | $77K | $81K | −$4K | -5% |
| Cash used in operations | $17.3M | $10.9M | $6.4M | +59% |
| Net loss absorbed | $11.8M | $21.0M | −$9.2M | -44% |
| Working capital & other | $5.6M | −$7.5M | $13.0M | — |
Questions
How much did Silence Therapeutics's revenue grow quarter over quarter in Q4 2025?
Silence Therapeutics's revenue fell $125K (-79%) from $159K in Q3 2025 to $34K in Q4 2025.